Gene: FPGS
Official Full Name: folylpolyglutamate synthaseprovided by HGNC
Gene Summary: This gene encodes the folylpolyglutamate synthetase enzyme. This enzyme has a central role in establishing and maintaining both cytosolic and mitochondrial folylpolyglutamate concentrations and, therefore, is essential for folate homeostasis and the survival of proliferating cells. This enzyme catalyzes the ATP-dependent addition of glutamate moieties to folate and folate derivatives. Alternative splicing results in transcript variants encoding different isoforms. [provided by RefSeq, Jan 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO37833 | FPGS Knockout cell line (HeLa) | Human | FPGS | 1:3~1:6 | Negative | Online Inquiry |
KO37834 | FPGS Knockout cell line (HCT 116) | Human | FPGS | 1:2~1:4 | Negative | Online Inquiry |
KO37835 | FPGS Knockout cell line (HEK293) | Human | FPGS | 1:3~1:6 | Negative | Online Inquiry |
KO37836 | FPGS Knockout cell line (A549) | Human | FPGS | 1:3~1:4 | Negative | Online Inquiry |
FPGS Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to facilitate the study of the folylpolyglutamate synthetase (FPGS) gene's role in cellular metabolism and drug response. These cell lines provide a vital tool for understanding the functional impacts of FPGS gene deletion, thereby enabling researchers to dissect the molecular pathways associated with folate metabolism and the cellular uptake of antifolate compounds used in cancer therapy.
The primary mechanism of action of these knockout cell lines lies in their ability to mimic conditions of FPGS deficiency, elucidating the subsequent physiological and biochemical alterations. FPGS is crucial for converting folates into polyglutamated forms, which enhances their retention and efficacy in metabolic processes. By introducing specific gene deletions, researchers can investigate how these alterations influence cell behavior, drug resistance, and metabolic disequilibrium, providing insights that are critical for both basic and applied biosciences.
In the realm of research and clinical applications, FPGS knockout cell lines play a pivotal role in cancer research, particularly in evaluating the efficacy of chemotherapeutic agents. Their unique ability to model FPGS deficiency allows for targeted studies on drug sensitivity and metabolic adaptations in various cancers, accelerating the discovery of novel therapeutic strategies. Compared to alternative models, these knockout lines offer superior specificity and relevance to human disease states, leading to more reliable and translatable results.
The inherent value of FPGS Gene Knockout Cell Lines extends to researchers and clinicians alike, facilitating advancements in precision medicine and targeted therapeutics. They provide a robust platform for comprehensive understanding and manipulation of folate-related pathways, driving forward innovations in cancer treatment.
With our extensive expertise in genetic engineering and commitment to high-quality biological research tools, our company is dedicated to providing exceptional products that enhance scientific discovery and clinical advancements.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.